Where does Heligenics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Heligenics's 3 recorded funding rounds.

Premier Alternatives

Heligenics

Las Vegas, NV · Founded 2015 · Privately Held (backing)

Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.

Last reported valuation

$17.2M

Oct 2026

Priced at

—

Total raised

$6.0M

Last round

Seed Round

Aug 2024

Cap table — not yet on record

Heligenics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Heligenics with a free account

·Watch Heligenics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Heligenics

Where does Heligenics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Heligenics's 3 recorded funding rounds.